News

Organoids have revolutionized science and medicine, providing platforms for disease modeling, drug testing, and understanding ...
New research reveals that the immune checkpoint molecule Tim-3 plays a critical role in how microglia, the brain’s immune cells, respond to Alzheimer’s disease.
Training the brain's immune system to recognize and clear toxic material is rapidly emerging as an promising way to put the ...
Tim-3 is an immune checkpoint molecule involved in immunity and inflammation recently linked to late-onset Alzheimer's ...
Tim-3, a molecule involved in immune regulation, hinders plaque removal in Alzheimer’s disease. Blocking it in microglia improved brain health in mice, making it a potential treatment target. Tim-3 is ...
In a study published in Cell, a research team led by Prof. Li Hanjie from the Shenzhen Institutes of Advanced Technology ...
SHENZHEN -- Chinese scientists have, for the first time, confirmed the existence of microglia in the peripheral nervous ...
Researchers from Charité - Universitätsmedizin Berlin and the Max Delbrück Center have identified the precise mechanism by ...
A research group led by Nagoya University Graduate School of Medicine in Japan has uncovered a potential mechanism linking maternal inflammation to delayed neurodevelopment in infants.
Age-related neurodegenerative disorders — motor neuron diseases, demyelinating diseases, Alzheimer’s disease, and other proteinopathies — are at an ‘inflection point.’ ...
Preclinical presentation highlights key, modality specific, pharmacological differentiations of VG-3927 - - First presentation of topline ...